IP Library Granted Patent US 12,064,503
Granted Patent B2
US 12,064,503 · App. 17/965,628 · Granted Aug 20, 2024

High-potency vitamin C and sugar alcohol topical formulations

Inventor: Jihoon P. Baek (Los Angeles, CA)
Assignee: ICB (an ABC) LLC
A61K8/676A61K8/345A61K8/42A61K8/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,064,503
App. No.
17/965,628
Granted
Aug 20, 2024
Kind
B2
Abstract

Topical formulations of L-ascorbic acid dissolved in a combination of a sugar alcohol agent, and a non-aqueous skin-compatible solvent are provided. The formulations are storage stable for an extended period of time without significant degradation of the L-ascorbic acid in the composition, and have desirable physical properties. The topical formulations can include high concentrations of the L-ascorbic acid. Topical compositions of this disclosure find use in treating or preventing a variety of cosmetic and/or dermatological conditions as well as to reduce the appearance of chronological and/or environmentally-caused skin aging.

Claims (36)

1. A storage stable topical liquid composition comprising:

a. 10% to 20% by weight ascorbic acid;

b. 5% to 10% by weight of xylitol; and

c. less than 10% by weight in total of one or more optional additional components;

d. dissolved in a non-aqueous skin-compatible solvent selected from the group consisting of 1,3 propanediol, 1,2 propanediol, 1,3 butanediol, 1,5 pentanediol, 1,2 hexanediol, 1,6 hexanediol, glycerol, and a combination thereof,

wherein the composition demonstrates less than 5 mol % degradation of the ascorbic acid after storage for 8 weeks at 40±2° C. in a sealed container.

2. The composition of claim 1 , wherein the composition comprises 7 to 10% by weight of xylitol.

3. The composition of claim 1 , wherein the composition comprises 15% by weight of ascorbic acid.

4. The composition of claim 1 , wherein the solvent is 1,3 propanediol, or a mixture of 1,3 propanediol and 1,2 hexanediol.

5. The composition of claim 1 , wherein the composition comprises the one or more additional components.

6. The composition of claim 1 , wherein the ascorbic acid is dissolved at a concentration that is above its maximum concentration in the solvent alone.

7. The composition of claim 1 , wherein the composition comprises:

e. 15% to 20% by weight ascorbic acid;

f. 7% to 10% by weight of xylitol; and

g. less than 10% by weight in total of one or more optional additional components;

h. dissolved in 1,3 propanediol, 1,2 propanediol, or a mixture of 1,3 propanediol and 1,2 hexanediol.

8. The composition of claim 7 , wherein the composition comprises 15% by weight of ascorbic acid.

9. The composition of claim 7 , wherein the composition comprises 7.5% by weight of xylitol.

10. The composition of claim 7 , wherein the composition, when applied to skin, reduces or eliminates pathogenic staphylococcus mutants while maintaining the integrity of Staphylococcus epidermis.

11. A ready-to-use topical preparation in a multi-use container which is pre-filled with a storage stable topical composition of claim 1 .

12. The composition of claim 1 , wherein the composition comprises:

a. 10% by weight ascorbic acid;

b. 5% by weight of xylitol; and

c. less than 10% by weight in total of one or more optional additional components;

d. wherein the solvent comprises 1,3 propanediol and 1,2-hexanediol.

13. A storage stable topical liquid composition consisting of:

a. 10% to 20% by weight ascorbic acid;

b. 5% to 10% by weight of xylitol; and

c. less than 10% by weight in total of one or more optional additional components;

d. dissolved in a mixture of 1,3-propanediol and 1,2-hexanediol, wherein the composition comprises 2.5% or less of urea.

14. The composition of claim 13 , wherein:

the ascorbic acid is 15% to 20% by weight of the composition; and

the xylitol is 7% to 10% by weight of the composition.

15. The composition of claim 13 , wherein:

the ascorbic acid is 10% by weight of the composition; and

the xylitol is 5% by weight of the composition.

Assignments (3)
ASSET PURCHASE AGREEMENT Recorded Apr 11, 2025
From: ICB (AN ABC), LLC
To: MF BEAUTY PARTNERS LLC
Reel/Frame 070820/0964 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2025
From: BAEK CLINICAL INC.
To: ICB (AN ABC), LLC
Reel/Frame 070781/0445 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2022
From: BAEK, JIHOON P.
To: BAEK CLINICAL INC.
Reel/Frame 061418/0850 →
Continuity (3)
Continuation PCTUS2021027827 · Apr 16, 2021
Provisional Application 63010884 · Apr 16, 2020
Related Publication 20230049595A1 · Feb 16, 2023